These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8369205)

  • 81. Management of the erythropoietic porphyrias.
    Mascaro JM
    Photodermatol Photoimmunol Photomed; 1998 Apr; 14(2):44-5. PubMed ID: 9638721
    [No Abstract]   [Full Text] [Related]  

  • 82. Erythropoietic protoporphyria.
    Lecha M
    Photodermatol Photoimmunol Photomed; 2003 Jun; 19(3):142-6. PubMed ID: 12914599
    [No Abstract]   [Full Text] [Related]  

  • 83. Gastrointestinal obstruction associated with multiple-dose activated charcoal.
    Watson WA; Cremer KF; Chapman JA
    J Emerg Med; 1986; 4(5):401-7. PubMed ID: 3805698
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Anaesthetic management of erythropoietic protoporphyria.
    Torrance JM
    Paediatr Anaesth; 2000; 10(5):571. PubMed ID: 11012967
    [No Abstract]   [Full Text] [Related]  

  • 85. Oral activated charcoal therapy.
    Reed MD
    Am J Emerg Med; 1988 May; 6(3):318. PubMed ID: 3370115
    [No Abstract]   [Full Text] [Related]  

  • 86. The Patient Perspective: A Matter of Minutes.
    Falchetto R
    Patient; 2020 Feb; 13(1):1-6. PubMed ID: 31784882
    [No Abstract]   [Full Text] [Related]  

  • 87. Comment on: Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients.
    Kumar S; Khatri M
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29419. PubMed ID: 34783443
    [No Abstract]   [Full Text] [Related]  

  • 88. Reply to: Comment on: Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients.
    Wang YM; Gloude NJ; Davies SM; Lucky AW; Nelson AS
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29432. PubMed ID: 34842348
    [No Abstract]   [Full Text] [Related]  

  • 89. Multiple doses of activated charcoal: time for reappraisal II.
    Tenenbein M
    Ann Emerg Med; 2003 Oct; 42(4):597-8; author reply 598-9. PubMed ID: 14533638
    [No Abstract]   [Full Text] [Related]  

  • 90. Ocular protection in congenital erythropoietic porphyria: A potential role for gaming glasses.
    Fityan A; Aneju GA; Morley AMS; Sarkany R
    Photodermatol Photoimmunol Photomed; 2023 Sep; 39(5):535-537. PubMed ID: 37306226
    [No Abstract]   [Full Text] [Related]  

  • 91. [Haematological aspects in a case of erythropoietic porphyria].
    VARADI S
    Br J Haematol; 1958 Jul; 4(3):270-80. PubMed ID: 13572738
    [No Abstract]   [Full Text] [Related]  

  • 92. Kerr Insta-Char Activated Charcoal Product.
    Saulson SS
    Am J Emerg Med; 1992 Jan; 10(1):97. PubMed ID: 1736926
    [No Abstract]   [Full Text] [Related]  

  • 93. Corneal abrasions secondary to activated charcoal.
    McKinney PE; Phillips S; Gomez HF; Brent J
    Am J Emerg Med; 1993 Sep; 11(5):562. PubMed ID: 8363692
    [No Abstract]   [Full Text] [Related]  

  • 94. Home administration of charcoal: can mothers administer a therapeutic dose?
    Scharman EJ
    J Emerg Med; 2002 May; 22(4):421-2. PubMed ID: 12113860
    [No Abstract]   [Full Text] [Related]  

  • 95. What is the impact of charcoal on human health and oral carcinogenesis?
    Panta P; Dhopathi SR; Reddy P
    Oral Oncol; 2022 Jan; 124():105514. PubMed ID: 34479821
    [No Abstract]   [Full Text] [Related]  

  • 96. Hypertrichosis and erythrodontia in congenital erythropoietic porphyria.
    Enciso L
    EJHaem; 2021 Aug; 2(3):640-641. PubMed ID: 35844723
    [No Abstract]   [Full Text] [Related]  

  • 97. [Porphyria and dermatology (report of several cases of erythropoietic porphyria)].
    Peryassú D; Gabriela L; Lacaz PS
    An Bras Dermatol; 1966; 41(2):75-92. PubMed ID: 6015271
    [No Abstract]   [Full Text] [Related]  

  • 98. Mutilating congenital erythropoeitic porphyria with blindness in a farmer.
    D'souza P; Dhamija A; Salgia P; Kothiwala RK
    Indian J Dermatol; 2011 Mar; 56(2):243-4. PubMed ID: 21716940
    [No Abstract]   [Full Text] [Related]  

  • 99. Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria.
    Egan DN; Yang Z; Phillips J; Abkowitz JL
    Blood; 2015 Jul; 126(2):257-61. PubMed ID: 25972160
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The effect of oral activated charcoal on the course of congenital erythropoietic porphyria.
    Hift RJ; Meissner PN; Kirsch RE
    Br J Dermatol; 1993 Jul; 129(1):14-7. PubMed ID: 8369205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.